CP-675,206 With Neoadjuvant Hormone Therapy in Patients With High Risk Prostate Cancer

Clinical trial NCT00075192 · COMPLETED

Trial details

NCT number: NCT00075192
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Prostatic Neoplasms

Start date: 2004-03-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.